Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma

Por Shiba, Satoshi, Kondo, Shunsuke, Ueno, Hideki, Morizane, Chigusa, Ikeda, Masafumi, Okusaka, Takuji
Publicado em 2012

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

Por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado no Cancer Sci (2014)

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

Por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado no Cancer Sci (2015)

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial

Por Terazawa, Tetsuji, Kondo, Shunsuke, Hosoi, Hiroko, Morizane, Chigusa, Shimizu, Satoshi, Mitsunaga, Shuichi, Ikeda, Masafumi, Ueno, Hideki, Okusaka, Takuji
Publicado em 2014

Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma

Por Ikeda, Masafumi, Ohkawa, Shinichi, Okusaka, Takuji, Mitsunaga, Shuichi, Kobayashi, Satoshi, Morizane, Chigusa, Suzuki, Ikue, Yamamoto, Shunsuke, Furuse, Junji
Publicado no Cancer Sci (2014)

Everolimus for Advanced Pancreatic Neuroendocrine Tumours: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial

Por Ito, Tetsuhide, Okusaka, Takuji, Ikeda, Masafumi, Igarashi, Hisato, Morizane, Chigusa, Nakachi, Kohei, Tajima, Takeshi, Kasuga, Akio, Fujita, Yoshie, Furuse, Junji
Publicado em 2012

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer

Por Suzuki, Eiichiro, Ikeda, Masafumi, Okusaka, Takuji, Nakamori, Shoji, Ohkawa, Shinichi, Nagakawa, Tatsuya, Boku, Narikazu, Yanagimoto, Hiroaki, Sato, Tosiya, Furuse, Junji
Publicado em 2013

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Por Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Publicado em 2013

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Por Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Publicado em 2013

Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

Por Okusaka, Takuji, Aramaki, Takeshi, Inaba, Yoshitaka, Nakamura, Shinichiro, Morimoto, Manabu, Moriguchi, Michihisa, Sato, Takashi, Ikawa, Yuta, Ikeda, Masafumi, Furuse, Junji
Publicado no Cancer Sci (2015)

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

Por Kudo, Masatoshi, Ikeda, Masafumi, Takayama, Tadatoshi, Numata, Kazushi, Izumi, Namiki, Furuse, Junji, Okusaka, Takuji, Kadoya, Masumi, Yamashita, Satoshi, Ito, Yuichiro, Kokudo, Norihiro
Publicado no J Gastroenterol (2016)

Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment

Por Okusaka, Takuji, Otsuka, Taiga, Ueno, Hideki, Mitsunaga, Shuichi, Sugimoto, Rie, Muro, Kei, Saito, Isao, Tadayasu, Yusuke, Inoue, Kohei, Loembé, Arsene‐Bienvenu, Ikeda, Masafumi
Publicado no Cancer Sci (2016)

Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment

Por Suyama, Koichi, Ikeda, Masafumi, Suzuki, Eiichiro, Kojima, Motohiro, Mitsunaga, Shuichi, Shimizu, Satoshi, Ohno, Izumi, Takahashi, Hideaki, Okuyama, Hiroyuki, Kuwahara, Akiko, Okusaka, Takuji, Furuse, Junji
Publicado em 2013

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

Por Ikeda, Kenji, Kudo, Masatoshi, Kawazoe, Seiji, Osaki, Yukio, Ikeda, Masafumi, Okusaka, Takuji, Tamai, Toshiyuki, Suzuki, Takuya, Hisai, Takashi, Hayato, Seiichi, Okita, Kiwamu, Kumada, Hiromitsu
Publicado no J Gastroenterol (2016)

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carc...

Por Ikeda, Masafumi, Shiina, Shuichiro, Nakachi, Kohei, Mitsunaga, Shuichi, Shimizu, Satoshi, Kojima, Yasushi, Ueno, Hideki, Morizane, Chigusa, Kondo, Shunsuke, Sakamoto, Yasunari, Asaoka, Yoshinari, Tateishi, Ryosuke, Koike, Kazuhiko, Arioka, Hitoshi, Okusaka, Takuji
Publicado em 2014

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Por Kudo, Masatoshi, Matsui, Osamu, Izumi, Namiki, Iijima, Hiroko, Kadoya, Masumi, Imai, Yasuharu, Okusaka, Takuji, Miyayama, Shiro, Tsuchiya, Kaoru, Ueshima, Kazuomi, Hiraoka, Atsushi, Ikeda, Masafumi, Ogasawara, Sadahisa, Yamashita, Tatsuya, Minami, Tetsuya, Yamakado, Koichiro
Publicado no Liver Cancer (2014)

A phase I study of the human anti‐activin receptor‐like kinase 1 antibody PF‐03446962 in Asian patients with advanced solid tumors

Por Doi, Toshihiko, Lee, Kyung‐Hun, Kim, Tae‐Min, Ohtsu, Atsushi, Kim, Tae Yong, Ikeda, Masafumi, Yoh, Kiyotaka, Gallo Stampino, Corrado, Hirohashi, Tomoko, Suzuki, Akiyuki, Fujii, Yosuke, Andrew Williams, James, Bang, Yung‐Jue
Publicado no Cancer Med (2016)

Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma

Por Hagihara, Atsushi, Ikeda, Masafumi, Ueno, Hideki, Morizane, Chigusa, Kondo, Shunsuke, Nakachi, Kohei, Mitsunaga, Shuichi, Shimizu, Satoshi, Kojima, Yasushi, Suzuki, Eiichiro, Katayama, Kazuhiro, Imanaka, Kazuho, Tamai, Chie, Inaba, Yoshitaka, Sato, Yozo, Kato, Mina, Okusaka, Takuji
Publicado no Cancer Sci (2014)

Phase I trial of GBS‐01 for advanced pancreatic cancer refractory to gemcitabine

Por Ikeda, Masafumi, Sato, Akihiro, Mochizuki, Nobuo, Toyosaki, Kayo, Miyoshi, Chika, Fujioka, Rumi, Mitsunaga, Shuichi, Ohno, Izumi, Hashimoto, Yusuke, Takahashi, Hideaki, Hasegawa, Hiromi, Nomura, Shogo, Takahashi, Ryuji, Yomoda, Satoshi, Tsuchihara, Katsuya, Kishino, Satoshi, Esumi, Hiroyasu
Publicado no Cancer Sci (2016)

Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study

Por Yamaue, Hiroki, Tsunoda, Takuya, Tani, Masaji, Miyazawa, Motoki, Yamao, Kenji, Mizuno, Nobumasa, Okusaka, Takuji, Ueno, Hideki, Boku, Narikazu, Fukutomi, Akira, Ishii, Hiroshi, Ohkawa, Shinichi, Furukawa, Masayuki, Maguchi, Hiroyuki, Ikeda, Masafumi, Togashi, Yosuke, Nishio, Kazuto, Ohashi, Yasuo
Publicado no Cancer Sci (2015)